ALGN
Align Technology·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 3
Consensus Rating "Buy"
High Gross Profit Margin
Significant Net Income Decline
High Cash/net Profit Ratio
Revenue Beats Expectation
RSI Overbought
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ALGN
Align Technology, Inc.
A leading global medical device company that develops a proprietary system for treating malocclusion and the misalignment of teeth
Healthcare Equipment and Supplies
--
01/26/2001
NASDAQ Stock Exchange
20,945
12-31
Common stock
410 North Scottsdale Road, Suite 1300, Tempe, Arizona 85288
Design, manufacture and sale of dental orthodontic treatment equipment
Align Technology, Inc., was founded in March 1997 and was incorporated in Delaware in April 1997. Align is a global medical device company engaged in the design, manufacture and sale of Invisalign clear aligners for the treatment of occlusal errors or misaligned teeth, by orthodontists and general dentists, ViveraTM retainers, iTeroTM intraoral scanners and dental services, and exocadTM computer-aided design and computer-aided manufacturing software for dental laboratories and dentists. The company's vision and strategy is to revolutionize orthodontic and restorative dentistry through digital treatment planning and implementation using Align digital PlatformTM, an integrated suite of proprietary technologies and services designed to provide seamless end-to-end solutions for patients, consumers, orthodontists, general practitioners and laboratory partners.
Earnings Call
Company Financials
EPS
ALGN has released its 2025 Q3 earnings. EPS was reported at 2.61, versus the expected 2.41, beating expectations. The chart below visualizes how ALGN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ALGN has released its 2025 Q3 earnings report, with revenue of 995.69M, reflecting a YoY change of 1.82%, and net profit of 56.75M, showing a YoY change of -51.06%. The Sankey diagram below clearly presents ALGN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


